374
Participants
Start Date
November 20, 2019
Primary Completion Date
October 10, 2020
Study Completion Date
October 10, 2020
Placebo
Placebo will be administered once daily
SPN-812
SPN-812 will be administered once daily and compared to Placebo
Altea Research Institute, Las Vegas
Bioscience Research, Mount Kisco
iResearch Atlanta, Decatur
Psych Atlanta, Marietta
Atlanta Center for Medical Research, Atlanta
Clinical Neuroscience Solutions, Inc, Jacksonville
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions Inc., Orlando
CNS Healthcare, Orlando
Research Centers of America, Hollywood
Meridien Research, Tampa
Meridien Research, Lakeland
Gulfcoast Research Center, Fort Myers
CNS Healthcare, Memphis
St. Charles Psychiatric Associates Midwest Research Center, Saint Charles
Psychiatric Associates, Overland Park
Alivation Research, LLC, Lincoln
Paradigm Research Professionals, Oklahoma City
FutureSearch Trials of Dallas, LLP, Dallas
Houston Clinical Trials, Houston
Family Psychiatry of the Woodlands, The Woodlands
BioBehavioral Research of Austin P.C., Austin
Ericksen Research & Development, Clinton
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas
Collaborative Neuroscience Network LLC, Torrance
Pharmacology Research Institute, Los Alamitos
Artemis Research Institute for Clinical Research, Riverside
Artemis Institute for Clinical Research, San Marcos
Artemis Institute for Clinical Research, San Diego
Pharmacology Research Institute, Newport Beach
Collaborative Neuroscience Network, Garden Grove
Northwest Clinical Trials, Bellevue
Hassman Research Institute, Berlin
Center for Emotional Fitness, Cherry Hill
Hassmann Research Institute, Marlton
Princeton Medical Institute, Princeton
The Medical Research Network LLC, New York
Supernus Pharmaceuticals, Inc.
INDUSTRY